CM.TO 1.58V 5.38NRIM 0CSU.TO 12.96NA.TO 2.87META -0.8EXPE 5.16CIGI.TO 3.74
Aptose Biosciences (APS.TO)

TSE:APS

Aptose Biosciences (APS.TO)

2.33
+0.13 (5.91%)
as of Jun 9, 2026, 7:56:30 pm Market Open.
10 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
BUY

Aptose Biosciences(APS.TO)

May 12, 2003
Well managed. Decent balance sheet. Has a huge beta which means that as the market goes up, this goes up a lot more. Very liquid.
Photo of Peter HodsonPeter HodsonUnlock Rating
$1.30

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
WEAK BUY

Aptose Biosciences(APS.TO)

May 02, 2003
Looks positive. Has a big following.
Photo of Michael SmedleyMichael SmedleyUnlock Rating
$1.39

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Aptose Biosciences(APS.TO)

Apr 25, 2003
(Was a top pick on Mar 27. Up 6%.) Still likes. Expects a lot more upside.
Photo of Robert FloydRobert FloydUnlock Rating
$1.60

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
BUY

Aptose Biosciences(APS.TO)

Apr 10, 2003
Should have a lot of upside, but earnings will take a while. Has one application in stage 3 with FDA. Good price.
Photo of Robert FloydRobert FloydUnlock Rating
$0.98

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
WEAK BUY

Aptose Biosciences(APS.TO)

Mar 31, 2003
A worthwhile speculative play.
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$0.98

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Aptose Biosciences(APS.TO)

Mar 27, 2003
Good products nearing approval. Can move up dramatically.
Photo of Robert FloydRobert FloydUnlock Rating
$0.85

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Aptose Biosciences(APS.TO)

Sep 03, 2002
Volatile. In a downtrend. Probably getting near a low.
Photo of Larry Berman CFA, CMT, CTALarry Berman CFA, CMT, CTAUnlock Rating
$0.56

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Aptose Biosciences(APS.TO)

Feb 01, 2002
News driven. Could be a long wait.
Photo of Robert FloydRobert FloydUnlock Rating
$1.08

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
BUY

Aptose Biosciences(APS.TO)

Jan 16, 2002
Good products in their pipeline. Good management.
Photo of Ray SteeleRay SteeleUnlock Rating
$1.25

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
BUY

Aptose Biosciences(APS.TO)

Dec 21, 2001
Could have some upside. Good management/cash position.
Photo of Robert FloydRobert FloydUnlock Rating
$1.17

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Aptose Biosciences(APS.TO)

Dec 21, 2001
Making progress in the FDA phases. Biotechs will be good. A cheap price.
Photo of Ray SteeleRay SteeleUnlock Rating
$1.17

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Aptose Biosciences(APS.TO)

Nov 09, 2001
New joint ventures but growth may take awhile.
Photo of Robert FloydRobert FloydUnlock Rating
$1.16

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Aptose Biosciences(APS.TO)

Aug 24, 2001
Products are too early in their stage. Too expensive. Have a lot of cash.
Photo of Martin Hubbes, CFAMartin Hubbes, CFAUnlock Rating
$1.25

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Aptose Biosciences(APS.TO)

Jun 04, 2001
A hit and miss sector. Volatile.
Photo of David DriscollDavid DriscollUnlock Rating
$1.60

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Aptose Biosciences(APS.TO)

May 15, 2001
Speculative. No earnings. Low price, but could drop evenmore.
Photo of Ross HealyRoss HealyUnlock Rating
$1.72

Stock price when the opinion was issued

$2.33

As of Jun 09, 2026. Market Open.

biotechnologypharmaceutical
Showing 16 to 30 of 44 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

RPRX 0.77$55.63
URA -1.8$44.12
BBD.B.TO 3.33$305.83
X.TO 0.55$50.44
TRI.TO -1.25$114.87
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video

Today's Top Picks

CM.TO 1.58$154.53
V 5.38$325.05
NRIM 0$
CSU.TO 12.96$2975.35
NA.TO 2.87$207.27

Popular Articles

Latest Sell Signals

MDA.TO -1.44$52.57
CPRT 0.45$31.31
TEVA 1.19$34.45
GLXY.TO -1.39$28.26
XNDU.TO 0.55$50.44

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Barry Schwartz

Barry Schwartz

Baskin Wealth Management

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Larry Berman CFA, CMT, CTA

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Mike Vinokur, CFA, CMT, and CFP

Mike Vinokur, CFA, CMT, and CFP

Propellus Wealth Partners/iA Private Wealth

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video